areas. The remaining patients are treated in two diÂerent hepatic diseases and groups at risk for exposure to areas: those patients with serious complications due to parenterally transmitted infectious agents, such as haechronic renal failure are dialysed in an in-hospital area and mophiliacs, patients with multiple transfused anaemia patients with uncomplicated chronic renal failure are treated and intravenous drug users [10] [11] [12] . However, there is in an area located outside the hospital. little information on the prevalence and consequences Haemodialysis machines in use in our centre were 2008E of HGV infection in patients on long-term haemodia-(Fresenius, Schweinfurt, Germany) and Monitral S (Hospal, lysis. In recently published studies [13] [14] [15] patients on Medolla, Italy). Dialysers (cellulose acetate, Miro-Nova 140, haemodialysis have been shown to be at increased risk Althin Medical, Miami, FL, USA; polysulphone, Bellco, for HGV infection. Although this virus seems to pro-Mirandola, Italy; polyacrylonitrile, Filtral 10 AN69, Hospal, Meyzieu, France) are not reused. The dialysate circuit is duce persistent infections, it has not been found to disinfected with sodium hypochlorite after each individual cause liver inflammation [13, 14] . The aim of this study session. was to determine the prevalence and the clinical Universal measures of asepsis (changing gloves after each implications of HGV infection in Spanish patients on patient manipulation, avoiding sharing of articles among haemodialysis, as well as to identify factors related to patients), disinfection of environmental surfaces and this infection in this particular group. machines are routinely done in our haemodialysis units.
Subjects and methods

Laboratory methods
HBsAg and anti-HCV were tested by ELISA ( HBsAg ELISA
Patients
Test System 3, and anti-HCV 3rd Generation ELISA Test respectively, Ortho Diagnostic System, Raritan, NJ). Ninety-six patients with end-stage renal disease were studied.
HGV-RNA was extracted from 140 ml of serum using a This figure includes all the patients on long-term haemodiacommercially available kit (QiAmp, Qiagen GmBH, Hilden, lysis treated at our Institution in January 1996. The main Germany) and recovered in a final volume of 50 ml of characteristics of these patients are shown in Table 1 Features of the haemodialysis unit followed by and additional extension at 72°C for 10 min. One positive and three negative controls were included in In our Institution HBsAg and anti-HIV positive patients on each experiment. The background signal of negative control long-term haemodialysis are treated in two special isolated ranged between 0.084 and 0.113. Samples giving a signal five times above the mean background signal were considered liver biopsy was not available, the diagnosis of cirrhosis was aESRD: end-stage renal disease; bHD: haemodialysis; cPlacing of a vascular access was not included.
defined by clinical, analytical and ultrasonographical criteria.
X. Forns et al. 958
Analytical criteria included a low platelet or leukocyte count in those infected with HGV alone (17%) (P=0.01) (<100 000/ml and 4000/ml respectively) and a low prothrom-( Table 2 ). In contrast, abnormal liver tests were frebin activity. Ultrasonographic criteria included the following quent among patients co-infected with HGV and other data: irregular liver echostructure, visualization of regenerat-hepatitis viruses. In fact, 10 of 13 patients ( 77%) ive patients infected with HGV alone; group 3, 13 patients coinfected with HGV and HBV and/or HCV, and group 4, 28 patients infected by HCV and/or HBV Results (Table 3 ) .
No diÂerences were found among these four groups Prevalence of HGV infection in terms of age, proportion of transfused patients and the amount of transfused blood. However, regarding HGV-RNA sequences were detected in 25 of 96 the amount of transfused blood, the low number of patients on haemodialysis (26%) and in six of 200 (3%) patients included in groups 2 and 3, and the nonblood donors (P<0.001). Thirteen of the 25 HGV normal distribution of this variable has to be taken RNA positive patients (52%) had evidence of infection into account in the analysis. by HBV, HCV or both ( Table 2 ) . None of the HGV-
The proportion of patients who were submitted to RNA positive donors had evidence of infection by surgical procedures was similar among the four groups. HCV or HBV.
Regarding other risk factors for HGV transmission, Evidences of liver cirrhosis were found in four one patient belonging to group 4 was a promiscuous patients (Table 2 ). In two of them a liver biopsy heterosexual man. No antecedents of illicit drug abuse confirming the diagnosis was available. In the were recorded in any patient. remaining two patients the diagnosis of cirrhosis was Time on haemodialysis was shorter in patients established by clinical, analytical and ultrasonographinfected with HGV alone (group 2; 3.1±3.5 years) ical criteria. In one of them a fibrogastroscopy showed compared to patients infected with other hepatitis the presence of oesophageal varices. No evidences of viruses (group 4; 7.6±5.8 years). The diÂerence was cirrhosis were present in the remaining 92 cases. statistically significant (P=0.04). However, persistent abnormalities of liver tests lasting more than 1 year were recorded in 32 patients (34%).
Biochemical abnormalities were more frequent in Discussion patients infected with HCV and/or HBV (61%) than Although the discovery of hepatitis C virus and the The prevalence of HGV infection has been evaluated in diÂerent population groups. Serum and plasma aAll patients with diagnosis of liver cirrhosis had liver test abnormalities.
samples from a significant number of volunteer blood donors from the US were recently analysed, and it was study a commercially available test for HGV detection was used [16 ] . The design of the primers used in this demonstrated that the prevalence of HGV infection in this specific group was 1.5%, with no diÂerences assay was based in nucleotide sequences of the HGV prototype [9] and for this reason a more extensive between patients with normal and abnormal aminotransferase values [9] . In our population of blood evaluation of the assay to test its sensitivity and specificity is still needed. However, cross-reactivity, i.e. donors, the prevalence of HGV infection is higher, and liver test abnormalities are rarely detected. Regarding amplification of other viral agents like HCV, has not been observed [16 ] . patients with community-acquired acute hepatitis, it seems that only a low proportion of cases of non-A-E
The proportion of patients infected solely with HGV showing liver test abnormalities was clearly low in hepatitis can be explained by HGV; the relevance of HGV in some cases of fulminant hepatitis is still under comparison to patients infected by HBV or HCV and our data suggest that HGV itself is not a frequent investigation [19, 20] . Finally, HGV prevalence in risk groups such as haemophiliacs or drug users is higher cause of chronic liver disease in patients on haemodialysis. These results are in concordance with those than in blood donors [9] [10] [11] [12] . Although chronic hepatitis does not seem to develop after HGV acquisition, obtained by Masuko et al., as none of the HGV infected patients in their study had clinical or analytical persistent viraemia is frequently demonstrated [9 ] .
Hepatitis viruses have become one of the main data suggesting liver disease [13 ] . In contrast, we show that evidences of chronic liver disease were frequent infectious problems in patients on long-term haemodialysis. After the introduction of measures aimed to when HGV positive patients were coinfected with other hepatitis viruses. Although liver biochemical tests are control the spread of hepatitis B virus infection in dialysis units, it became evident that patients on not always an appropriate guide to the presence and severity of liver disease in patients on haemodialysis, haemodialysis are at increased risk of acquiring hepatitis C virus. Although remarkably variable, the we examined the analytical markers of portal hypertension and the abdominal ultrasonographical studies in prevalence of HCV infection in haemodialysis patients is consistently higher than in blood donors from the all of these patients.
After several studies on HCV transmission, it became same area, demonstrating that these patients are a high-risk population [4] .
clear that transfusion with non-screened blood was strongly involved in the past in the acquisition of HCV In a recent report [13 ] , a large cohort of patients on maintenance haemodialysis was studied to determine in patients on long-term haemodialysis, but this mechanism does not appear to be currently incriminated. whether they were infected by HGV. In the referred study, HGV was detected in 3.1% of the patients on In fact, the introduction of the screening of blood products for HCV makes acquisition of this virus by haemodialysis, as compared with 0.9% of healthy blood donors. This diÂerence was statistically significant, blood transfusion very unlikely [21 ] and nosocomial transmission within the haemodialysis units appears to pointing out that patients on maintenance haemodialysis were at increased risk for HGV infections.
represent the main mechanism of HCV acquisition [7, 8, 22] . It seems possible that similar mechanisms of In our study we demonstrate that 25% of patients on long-term haemodialysis were infected with HGV, transmission can operate in the acquisition of other Flaviviridae, such as HGV. Transfusion of blood prodwhich is clearly higher than the prevalence reported by Masuko et al. [13] . In this study the authors used ucts could represent a relevant mechanism of HGV transmission. Although the use of erythropoietin has primers deduced from a variable region of the HGV genome for PCR analysis. Mismatches between the decreased the transfusion rate in patients on haemodialysis, the results of this study show that they still primers and the viral genome could prevent the amplification of some HGV strains or decrease the sensitivity receive a considerable amount of blood products. This fact could explain the high proportion of HGV infected of the assay. Therefore it cannot be excluded that the prevalence reported by Masuko et al. underevaluates patients as well as the relatively rapid acquisition of this virus in patients on maintenance haemodialysis. the epidemiological relevance of HGV infection in patients on haemodialysis in Japan. In contrast to the This becomes stronger considering the prevalence of HGV in blood donors and the fact that liver function Japanese study, a higher prevalence of HGV infection has been reported in patients on maintenance haemo-tests are frequently normal in these patients. The variability in the prevalence of HGV infection in dialysis from France and Indonesia [14, 15] . In our hepatitis C virus by second generation test in hemodialyzed various haemodialysis populations [13-15 ] could be patients. Kidney Int 1993; 43: S149-S152 attributed, at least in part, to the diÂerent prevalence 
